Nutrition in the Prevention and Treatment of Abdominal Obesity (2nd Ed.)

Coordinator: Watson Ronald Ross

Language: Anglais
Cover of the book Nutrition in the Prevention and Treatment of Abdominal Obesity

Subjects for Nutrition in the Prevention and Treatment of Abdominal...

Approximative price 242.37 €

In Print (Delivery period: 14 days).

Add to cartAdd to cart
Publication date:
600 p. · 21.6x27.6 cm · Paperback

Obesity research continues to accelerate at an impressive pace. The incidence of obesity also continues to accelerate resulting in an unprecedented epidemic that shows no significant signs of slowing down any time soon. Nutrition in the Prevention and Treatment of Abdominal Obesity, Second Edition focuses on the important role that exercise, dietary changes, and foods play in promoting as well as reducing visceral fat. Nutritionists, dieticians, and healthcare providers seeking to address the abdominal obesity epidemic will use this comprehensive resource as a tool in their long-term goal of preventing chronic diseases, especially heart, vascular, and diabetic diseases.

This upadated reference serves as a progress report on the way to achieving mastery over the disease that is obesity. It is an important tool in proving a link to new knowledge, serving researcher and clinician alike, but in different ways. Experts from a broad range of disciplines are dealing with the consequences of excessive abdominal fat: cardiology, diabetes research, studies of lipids, endocrinology and metabolism, nutrition, obesity, and exercise physiology. Their chapters define a range of dietary approaches to reducing risk and associated chronic diseases

Part 1: Epidemiology and Pathophysiology of Abdominal Obesity 1. Diet and Irritable Bowel Syndrome, with a Focus on Appetite-Regulating Gut Hormones 2. Work and Abdominal Obesity Risk 3. Effects of Dietary Patterns and Physical Activity on the Establishment of Abdominal Obesity in Adolescents 4. Lifestyle Factors Affecting Abdominal Obesity in Children and Adolescents: Risks and Benefits 5. Female Cancer Survivorship and Obesity 6. Evaluation of Visceral Fat in Massive Obesity 7. Beyond Nutrition Is There Any Role for Physical Activity in Nonalcoholic Fatty Liver Disease Therapy 8. Abdominal Fat and African-Americans: Incidence and Relationship to Disease

Part 2: Abdominal Obesity and Metabolic Syndrome 9. Visceral Fat and Hypertension: Sex Differences 10. Remission of Metabolic Syndrome After Sleeve Gastrectomy 11. Serum Magnesium and Abdominal Obesity and its Consequences

Part 3: Nutrition, abdominal obesity, and type 2 diabetes 12. Abdominal Adipose Tissue and Insulin Resistance: The Role of Ethnicity 13. Visceral Fat Predicts Ectopic Fat Accumulation Mechanisms and Health Consequences 14. Blood Pressure Regulation in Abdominal Obesity

Part 4: Mechanisms of Altering Abdominal Obesity 15. Effect of Glucagon-Like Peptide 1 Receptor Agonists on Visceral Fat Adiposity, Appetite, and Food Preference 16. Effects of Sleeve Gastrectomy on Calcium Metabolism 17. Intermittent Versus Daily Calorie Restriction in Visceral Fat Loss 18. Stress-Induced Eating Dampens Physiological and Behavioral Stress Responses 19. Fructose-Induced Hypertriglyceridemia: A Review 20. Impact of Sex and Lifestyle of Adolescents and Their Parents on Obesity 21. Physical Activity, Inflammatory Cytokines, Endothelial Dysfunction, and Risk of Coronary Artery Diseases in Visceral Obesity

Part 5: Dietary Foods and Visceral Fat Accumulation and Removal 22. Fermented Soypastes, Doenjang and Cheonggukjang, and Obesity 23. Alcohol Intake and Hormonal Dysregulation of Food Intake in Visceral Fat Accumulation 24. Coffee Intake and Obesity 25. Bread Intake and Abdominal Fat 26. Role of the Immune System in Obesity-Associated Inflammation and Insulin Resistance 27. Metabolic Effects of Abdominal Fats in Animal Models and Humans 28. Appetite and Reward Signals in the Brain: Sugar Intake Effects on Brain Activity as Measured by Functional Magnetic Resonance Imaging

Part 6: Dietary Supplements and Visceral Obesity 29. Flaxseed Secoisolariciresinol Diglucoside and Visceral Obesity: A Closer Look at its Chemical Properties, Absorption, Metabolism, Bioavailability, and Effects on Visceral Fat, Lipid Profile, Systemic Inflammation, and Hypertension 30. Carotenoids as a Nutraceutical Therapy for Visceral Obesity 31. Nutritional Deficiencies in Obese Sleeve Gastrectomy Patients

Part 7: Macromolecules in Foods and Diets and Abdominal Obesity 32. Dairy Whey Proteins and Obesity 33. Probiotics to Treat Visceral Obesity and Related Liver Disease 34. Beta-Cryptoxanthin, a Novel Carotenoid Derived from Satsuma Mandarin, Prevents Abdominal Obesity 35. A Diet with Carbohydrates Eaten Primarily at Dinner: An Innovative, Nutritional Approach to End the Vicious Cycle of Abdominal Obesity

Part 8: Micromolecules and Nutrients as Modulators of Visceral Fat 36. Effects of Different Dietary Fatty Acids on Human Energy Balance, Body Weight, Fat Mass, and Abdominal Fat 37. Conjugated Linoleic Acid in Human Health Effects on Weight Control 38. Essential Amino Acid Supplementation for the Prevention and Treatment of Obesity

Part 9: Activity of Adipocytes: Role in Growth and Accumulation of Fat 39. Fibroblast Growth Factor 21 is a Regulator of Energy Metabolism in the Liver and Adipose Tissue 40. Genetics of Abdominal Obesity 41. The Role of Site-Specific Adipose Tissue Fatty Acid Composition in Obesity

Part 10: Fiber and Visceral Obesity 42. Using Psyllium to Prevent and Treat Obesity Comorbidities 43. Whole Grains in the Prevention and Treatment of Abdominal Obesity

Academic, government, and corporate researchers in nutrition, diet, and endocrinology; graduate students in nutrition, epidemiology and public health; and practicing nutritionists, dietitians, and endocrinologists.

Ronald Ross Watson, PhD, is a Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia, and USA which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring at a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson’s career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books, particularly in health, and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco and drugs of abuse in heart function and disease in mouse models.